Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant
Go back to Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant| (NASDAQ: COCH) | Delayed: 0.68 +0.01 (1.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.67 | 52 Week High | $ | |||
| Open | $0.64 | 52 Week Low | $ | |||
| Day High | $0.73 | P/E | N/A | |||
| Day Low | $0.63 | EPS | $ | |||
| Volume | 319,659 | |||||

